Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Daily News

How Mediterranean Diets Might Cut Mortality in Women: New Insights

Yael L. Maxwell

June 05, 2024

News Daily News

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

Todd Neale

February 02, 2024

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Todd Neale

October 11, 2023

News Daily News

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

L.A. McKeown

February 06, 2023

News Daily News

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed

Todd Neale

August 12, 2022

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

News Daily News

Best Exercise for Heart Health? Some Hints of Intensity’s Role

Michael O'Riordan

December 02, 2021

News Daily News

Biggest Benefits of Regular Fish Consumption Lie in Secondary Prevention

Michael O'Riordan

March 11, 2021

News Conference News AHA 2020

Obesity Worsens Outcomes in COVID-19, Especially for Younger Adults

Shelley Wood

November 18, 2020

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Daily News

CV Risk Factors Make Even Younger COVID-19 Patients More Vulnerable

L.A. McKeown

September 09, 2020

News Daily News

GATEWAY at 3 Years: Bariatric Surgery Continues to Reduce Need for Antihypertensive Drugs

L.A. McKeown

August 31, 2020

News Daily News

One Egg a Day? No Link to Risk of CVD, Mega-Meta-analysis Says

Michael O'Riordan

March 06, 2020

News Daily News

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Shelley Wood

January 14, 2020

News Conference News ESC 2018

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Michael O'Riordan

August 26, 2018

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

Advertisement

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

How Mediterranean Diets Might Cut Mortality in Women: New Insights

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

Best Exercise for Heart Health? Some Hints of Intensity’s Role

Biggest Benefits of Regular Fish Consumption Lie in Secondary Prevention

Obesity Worsens Outcomes in COVID-19, Especially for Younger Adults

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

CV Risk Factors Make Even Younger COVID-19 Patients More Vulnerable

GATEWAY at 3 Years: Bariatric Surgery Continues to Reduce Need for Antihypertensive Drugs

One Egg a Day? No Link to Risk of CVD, Mega-Meta-analysis Says

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content